Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.02 -0.04 (-0.31%) Market Cap: 40.86 Bil Enterprise Value: 68.74 Bil PE Ratio: 40.31 PB Ratio: 0.88 GF Score: 68/100

Full Year 2022 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

May 11, 2022 / 10:00AM GMT
Release Date Price: $13.93 (-4.06%)
Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Manager of IR and Global Finance

Presentation
May 11, 2022 / 10:00AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Ayako Iwamuro
Takeda Pharmaceutical Company Limited - Manager of IR and Global Finance
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot